FDA approves Winrevair for pulmonary arterial hypertension in adults
by Lori SolomonThe U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.The FDA previously granted
Updated on: March 30,2024
FDA approves Winrevair for pulmonary arterial hypertension in adults
by Lori SolomonThe U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.The FDA previously granted
Updated on:March 30,2024
